Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine/Naloxone Treatment for Opioid Dependence
NCT00000326Phase 2Withdrawn
- Sponsor
- University of Colorado Denver
- Start
- Apr 1997
- Primary completion
- Aug 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of buprenorphine + naloxone in opioid use disorder (OUD) (2 arms), sponsored by University of Colorado Denver. Primary endpoints: Drug use, Retention and 10 more. Planned start Apr 1997; status: withdrawn.
02
Drugs
buprenorphine + naloxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00000326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000326.